Inrig Jula sold TVTX
December 24, 2025 · Form 4 insider transaction
Inrig Jula sold 15,000 shares of Travere Therapeutics, Inc. at $42.00 per share, a transaction worth $630.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 5 days after the transaction.
Footnotes
This sale was made pursuant to a written plan adopted on May 28, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.; The weighted average sale price for the transaction reported was $42.0003, and the range of prices were between $42.00 and $42.015. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.